{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:51:55Z","timestamp":1781657515162,"version":"3.54.5"},"reference-count":28,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify factors associated with need for pharmacotherapy among patients with glucose intolerance and 1 elevation on 3-hour oral glucose tolerance test (OGTT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective cohort study of singleton gestations 24 weeks or greater with at least 1 elevation on OGTT. The primary outcome was need for pharmacotherapy for glycemic control. To evaluate timing of OGTT elevation with need for pharmacotherapy, a logistic regression model controlled for maternal race\/ethnicity, body mass index (BMI), gestational age at time of OGTT, age, parity, history of gestational diabetes, and history of large neonate. The need for pharmacotherapy was assessed based on number and extent of testing elevations. A predictive model based on linear discriminant analysis was developed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 480 patients had 1 OGTT elevation; of these, 19.2% required pharmacotherapy. Fasting elevations were most associated with development of medication-requiring diabetes. A predictive model for risk of pharmacotherapy in patients with an abnormal OGTT based on BMI and extent of elevation at each OGTT time point increased the identification of patients requiring pharmacotherapy by 15.4%. At least 2 OGTT elevations occurred in 376 patients; these patients were more likely to require pharmacotherapy for glycemic control compared to those with 1 elevation. Patients with increasing BMI values had increased need for pharmacotherapy regardless of the number of abnormal values.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among patients with 1 OGTT elevation, fasting elevation and BMI are predictive of need for anti-glycemic medications. Predictive models may be useful in assessing need for pharmacotherapy for patients with abnormal OGTT, not otherwise meeting criteria for gestational diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag062","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:48:23Z","timestamp":1770814103000},"page":"1940-1948","source":"Crossref","is-referenced-by-count":0,"title":["The need for pharmacotherapy among patients with one or more elevations on glucose tolerance test"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1507-0656","authenticated-orcid":false,"given":"Lizelle","family":"Comfort","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Northwell , New Hyde Park, NY 11042 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6500-0496","authenticated-orcid":false,"given":"Alexis","family":"Benjamin","sequence":"additional","affiliation":[{"name":"Zucker School of Medicine at Hofstra\/Northwell , Hempstead, NY 11549 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2019-4857","authenticated-orcid":false,"given":"Emma","family":"Brenner","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Northwell , New Hyde Park, NY 11042 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2310-6003","authenticated-orcid":false,"given":"David","family":"Krantz","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Northwell , New Hyde Park, NY 11042 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Bonanno","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Northwell , New Hyde Park, NY 11042 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5146-1283","authenticated-orcid":false,"given":"Heather","family":"Levin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Northwell , New Hyde Park, NY 11042 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alefiya","family":"Faizullabhoy","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Northwell , New Hyde Park, NY 11042 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6736-1105","authenticated-orcid":false,"given":"Burton","family":"Rochelson","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Northwell , New Hyde Park, NY 11042 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"2","key":"2026061619573451700_dgag062-B1","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1097\/AOG.0000000000002501","article-title":"ACOG practice bulletin No. 190: gestational diabetes Mellitus","volume":"131","year":"2018","journal-title":"Obstetrics & Gynecology"},{"issue":"2","key":"2026061619573451700_dgag062-B2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/AOG.0b013e3181ae8d85","article-title":"Carpenter-coustan criteria compared with the national diabetes data group thresholds for gestational diabetes mellitus","volume":"114","author":"Cheng","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2026061619573451700_dgag062-B3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2016.04.040","article-title":"Single abnormal value on 3-hour oral glucose tolerance test during pregnancy is associated with adverse maternal and neonatal outcomes: a systematic review and metaanalysis","volume":"215","author":"Roeckner","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2026061619573451700_dgag062-B4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/14767050802610344","article-title":"Effect of different degrees of glucose intolerance on maternal and perinatal outcomes","volume":"22","author":"Biri","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"2026061619573451700_dgag062-B5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/jp.2015.215","article-title":"Diagnostic ability of elevated 1-h glucose challenge test","volume":"36","author":"Temming","year":"2016","journal-title":"J Perinatol"},{"issue":"14","key":"2026061619573451700_dgag062-B6","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1055\/s-0037-1604243","article-title":"Predictive characteristics of elevated 1-hour glucose challenge test results for gestational diabetes","volume":"34","author":"Tita","year":"2017","journal-title":"Am J Perinatol"},{"issue":"3","key":"2026061619573451700_dgag062-B7","first-page":"344","article-title":"Glucose tolerance test: degree of glucose abnormality correlates with neonatal outcome","volume":"81","author":"Berkus","year":"1993","journal-title":"Obstet Gynecol"},{"key":"2026061619573451700_dgag062-B8","first-page":"278","article-title":"Criteria for the oral glucose tolerance test in pregnancy","volume":"13","author":"O'Sullivan","year":"1964","journal-title":"Diabetes"},{"issue":"5","key":"2026061619573451700_dgag062-B9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/AOG.0000000000001383","article-title":"Carpenter-coustan compared with national diabetes data group criteria for diagnosing gestational diabetes","volume":"127","author":"Harper","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2026061619573451700_dgag062-B10","first-page":"S129","article-title":"286: one abnormal value in a GTT: does it matter which one?","volume":"208","author":"Chavan","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2026061619573451700_dgag062-B11","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.ajog.2007.10.373","article-title":"356: one abnormal value on the GTT: does it matter which?","volume":"197","author":"Playforth","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2026061619573451700_dgag062-B12","doi-asserted-by":"crossref","first-page":"224.e1","DOI":"10.1016\/j.ajog.2014.08.027","article-title":"The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes","volume":"212","author":"Mayo","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"2026061619573451700_dgag062-B13","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3390\/nu11081812","article-title":"Energy intake requirements in pregnancy","volume":"11","author":"Most","year":"2019","journal-title":"Nutrients"},{"issue":"6","key":"2026061619573451700_dgag062-B14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/dia.2018.0150","article-title":"Accuracy of a factory-calibrated, real-time continuous glucose monitoring system during 10 days of use in youth and adults with diabetes","volume":"20","author":"Wadwa","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2026061619573451700_dgag062-B15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jclinepi.2008.11.004","article-title":"Absolute risk reductions, relative risks, relative risk reductions, and numbers needed to treat can be obtained from a logistic regression model","volume":"63","author":"Austin","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"2026061619573451700_dgag062-B16","unstructured":"Comfort L, Krantz D. Supplemental Table 1. Reference parameters used to create the predictive model for need for pharmacotherapy. Version 1. Zenodo. Published January 17, 2026. 10.5281\/zenodo.18276599"},{"key":"2026061619573451700_dgag062-B17","unstructured":"Comfort L, Krantz D. Supplemental Table 2: Evaluation of different risk cutoffs within the \u201c1 elevated value\u201d group to characterize how well each cutoff identifies patients who require pharmacotherapy. Version 1. Zenodo. Published January 17, 2026. 10.5281\/zenodo.18276663"},{"issue":"25","key":"2026061619573451700_dgag062-B18","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1056\/NEJMoa040405","article-title":"Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery","volume":"351","author":"Landon","year":"2004","journal-title":"N Engl J Med"},{"key":"2026061619573451700_dgag062-B19","author":"National Institute of Child Health and Human Development"},{"issue":"11","key":"2026061619573451700_dgag062-B20","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3390\/metabo12111040","article-title":"Development and validation of risk prediction models for gestational diabetes Mellitus using four different methods","volume":"12","author":"Wang","year":"2022","journal-title":"Metabolites"},{"issue":"1","key":"2026061619573451700_dgag062-B21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41387-021-00173-0","article-title":"Prediction of insulin treatment in women with gestational diabetes mellitus","volume":"11","author":"Eleftheriades","year":"2021","journal-title":"Nutr Diabetes"},{"issue":"2","key":"2026061619573451700_dgag062-B22","first-page":"105","article-title":"Predicting the need for medical therapy in patients with mild gestational diabetes","volume":"31","author":"Mendez-Figueroa","year":"2014","journal-title":"Am J Perinatol"},{"issue":"19","key":"2026061619573451700_dgag062-B23","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.3390\/ijerph17196990","article-title":"Correlation between oral glucose tolerance test abnormalities and adverse pregnancy outcomes in gestational diabetes: a cross-sectional study","volume":"17","author":"Kalok","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"2026061619573451700_dgag062-B24","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/GRF.0b013e31815a5494","article-title":"Metabolic changes in pregnancy","volume":"50","author":"Lain","year":"2007","journal-title":"Clin Obstet Gynecol"},{"issue":"7","key":"2026061619573451700_dgag062-B25","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2337\/dc08-0126","article-title":"Isolated hyperglycemia at 1 hour on oral glucose tolerance test in pregnancy resembles gestational diabetes mellitus in predicting postpartum metabolic dysfunction","volume":"31","author":"Retnakaran","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"2026061619573451700_dgag062-B26","first-page":"95","article-title":"Effect of number of abnormal oral glucose tolerance test (OGTT) values on birthweight in women with gestational diabetes","volume":"137","author":"K\u00f6s\u00fcs","year":"2013","journal-title":"Indian J Med Res"},{"issue":"3","key":"2026061619573451700_dgag062-B27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0002-9378(89)90361-X","article-title":"Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy","volume":"161","author":"Langer","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"19","key":"2026061619573451700_dgag062-B28","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","article-title":"Metformin versus insulin for the treatment of gestational diabetes","volume":"358","author":"Rowan","year":"2008","journal-title":"N Engl J Med"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag062\/66863229\/dgag062.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/7\/1940\/66863229\/dgag062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/7\/1940\/66863229\/dgag062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:57:42Z","timestamp":1781654262000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/7\/1940\/8475165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,2,12]]},"published-print":{"date-parts":[[2026,6,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag062","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,2,12]]}}}